Fidelity Investments’s Kindred Biosciences, Inc. KIN Stock Holding History

Fidelity Investments’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	5361
2021 Q2	$0	Buy	+1	New	+$6	﹤0.01%	5181
2016 Q4	–	Sell	-106,458	Closed	-$529K	–	2738
2016 Q3	$529K	Sell	106,458 -113,492	-52%	-$480K	﹤0.01%	2543
2016 Q2	$779K	Buy	+219,950	New	+$809K	﹤0.01%	2499
2014 Q3	–	Sell	-2,161,052	Closed	-$40.3M	–	2848
2014 Q2	$40.3M	Buy	2,161,052 +796,800	+58%	+$13.5M	0.01%	1443
2014 Q1	$25.3M	Buy	1,364,252 +264,252	+24%	+$5.04M	﹤0.01%	1660
2013 Q4	$12.3M	Buy	+1,100,000	New	+$13.1M	﹤0.01%	1902

Other funds holding KIN

CFO

CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return

Fidelity Investments's KIN Position: Q3 2021 in Review

Fidelity Investments sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 1 share.

Fidelity Investments first reported a position in KIN in Q4 2013 and held it in 6 quarters. The position peaked at $40.3M in Q2 2014. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

Fidelity Investments reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
Fidelity Investments sold 1 Kindred Biosciences, Inc. share in Q3 2021.
Fidelity Investments first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 6 quarters.
Fidelity Investments's Kindred Biosciences, Inc. position peaked at $40.3M in Q2 2014.
1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Fidelity Investments's 13F filing for Q3 2021, filed 15 Nov 2021.